NCT07569159 clinical trial report covering Methylenedioxymetamfetamine, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07570862 clinical trial report covering FT-819, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07569965 clinical trial report covering Fludarabine Phosphate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20261766 clinical trial report covering Interferon alpha-2b (Beijing Kawin Technology), Phase 2, endpoints, sponsor, geography, readout timing and developm

CTR20261735 clinical trial report covering CG-001(ComGen), Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07574385 clinical trial report covering ALX006(AILUX), Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07572396 clinical trial report covering (-)-Epigallocatechin Gallate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07572552 clinical trial report covering Silibinin, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07572383 clinical trial report covering [68Ga]CBP8, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07573670 clinical trial report covering Blinatumomab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07573696 clinical trial report covering Alpelisib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20261669 clinical trial report covering NC527-X, Phase 2, endpoints, sponsor, geography, readout timing and development white space.